Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07534735) titled 'Growth and Health Efficacy of Novel Infant Formula : A Randomized Trial' on April 10.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Other. Masking: None (Open Label).
Primary Sponsor: Biostime (Changsha) Nutrition Foods Limited
Condition:
Infant Growth
Intervention:
Dietary Supplement: Investigational Formula 1
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: May 2026
Target Sample Size: 120
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/study/NCT07534735
Disclaimer: Cu...